NKG2D defines tumor‐reacting effector CD8 + T cells within tumor microenvironment-Reference-Cited by-同舟云学术

NKG2D defines tumor‐reacting effector CD8 + T cells within tumor microenvironment

Published:2021-07-28 Issue:9 Volume:112 Page:3484-3490
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Mojic Marija¹,Shitaoka Kiyomi²,Ohshima Chikako¹,Ucche Sisca¹,Lyu Fulian²,Hamana Hiroshi²,Tahara Hideaki³⁴^ORCID,Kishi Hiroyuki²,Hayakawa Yoshihiro¹^ORCID

Affiliation:

1. Institute of Natural Medicine University of Toyama Toyama Japan

2. Department of Immunology Graduate School of Medicine and Pharmaceutical Sciences (Medicine) Toyama Japan

3. The, Institute of Medical Science The University of Tokyo Tokyo Japan

4. Department of Cancer Drug Discovery and Development, Research Center Osaka International Cancer Institute Osaka Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Yasuda Memorial Medical Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15050

Reference32 articles.

1. Features of responding T cells in cancer and chronic infection

2. Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

3. High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer

4. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

5. The blockade of immune checkpoints in cancer immunotherapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced altered self-presentation increases tumor immunogenicity;Biomedicine & Pharmacotherapy;2023-09

2. GSTA4 Governs Melanoma Immune Resistance and Metastasis;Molecular Cancer Research;2022-09-27

3. Evaluation of chimeric antigen receptor of humanized rabbit‐derived T cell receptor‐like antibody;Cancer Science;2022-07-31